+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neoantigen"

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035 - Product Thumbnail Image

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035

  • Report
  • March 2025
  • 1048 Pages
  • Global
From
Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 - Product Thumbnail Image

Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030

  • Report
  • November 2024
  • 600 Pages
  • Global
From
Immuno-oncology Clinical Trials Market by Therapy Type, Trial Phase, Indication, Sponsor Type, Trial Type, Patient Enrollment - Global Forecast to 2030 - Product Thumbnail Image

Immuno-oncology Clinical Trials Market by Therapy Type, Trial Phase, Indication, Sponsor Type, Trial Type, Patient Enrollment - Global Forecast to 2030

  • Report
  • May 2025
  • 189 Pages
  • Global
From
Immuno Oncology Assays Market by Technology Type, Application, End User, Product, Indication - Global Forecast to 2030 - Product Thumbnail Image

Immuno Oncology Assays Market by Technology Type, Application, End User, Product, Indication - Global Forecast to 2030

  • Report
  • May 2025
  • 195 Pages
  • Global
From
Cancer Immunotherapy Market by Therapy Type, Indication, Mechanism Of Action, Line Of Therapy, Route Of Administration, End User - Global Forecast to 2030 - Product Thumbnail Image

Cancer Immunotherapy Market by Therapy Type, Indication, Mechanism Of Action, Line Of Therapy, Route Of Administration, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 180 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing Market by Service Type, Therapeutic Modality, Workflow Stage, End User - Global Forecast to 2030 - Product Thumbnail Image

Cancer Immunotherapy Drug Discovery Outsourcing Market by Service Type, Therapeutic Modality, Workflow Stage, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 185 Pages
  • Global
From
Tumor-Infiltrating Lymphocyte Therapy Market by Indication, Cell Source, End User, Distribution Channel, Manufacturing Model - Global Forecast to 2030 - Product Thumbnail Image

Tumor-Infiltrating Lymphocyte Therapy Market by Indication, Cell Source, End User, Distribution Channel, Manufacturing Model - Global Forecast to 2030

  • Report
  • May 2025
  • 184 Pages
  • Global
From
Neoantigen Targeted Therapies Market by Therapy Modality, Treatment Approach, Route of Administration, Age Group, Target Disease Indication, End-User - Global Forecast to 2030 - Product Thumbnail Image

Neoantigen Targeted Therapies Market by Therapy Modality, Treatment Approach, Route of Administration, Age Group, Target Disease Indication, End-User - Global Forecast to 2030

  • Report
  • May 2025
  • 182 Pages
  • Global
From
TCR Therapy Market Report 2025 - Product Thumbnail Image

TCR Therapy Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2025 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Drugs for Immunotherapy Market Report 2025 - Product Thumbnail Image

Drugs for Immunotherapy Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Allogeneic T Cell Therapies Market Report 2025 - Product Thumbnail Image

Allogeneic T Cell Therapies Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Neoantigen Targeted Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Neoantigen Targeted Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • June 2025
  • 211 Pages
  • Global
From
Nasopharyngeal Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Nasopharyngeal Cancer Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 288 Pages
  • Global
From
Personalized Cancer Medicines - Global Strategic Business Report - Product Thumbnail Image

Personalized Cancer Medicines - Global Strategic Business Report

  • Report
  • June 2025
  • 267 Pages
  • Global
From
Checkpoint Inhibitor Refractory Cancer - Global Strategic Business Report - Product Thumbnail Image

Checkpoint Inhibitor Refractory Cancer - Global Strategic Business Report

  • Report
  • June 2025
  • 287 Pages
  • Global
From
Plasmid DNA Contract Manufacturing - Global Strategic Business Report - Product Thumbnail Image

Plasmid DNA Contract Manufacturing - Global Strategic Business Report

  • Report
  • June 2025
  • 66 Pages
  • Global
From
Hyper Personalized Medicines - Global Strategic Business Report - Product Thumbnail Image

Hyper Personalized Medicines - Global Strategic Business Report

  • Report
  • June 2025
  • 390 Pages
  • Global
From
m-RNA Synthesis Services - Global Strategic Business Report - Product Thumbnail Image

m-RNA Synthesis Services - Global Strategic Business Report

  • Report
  • June 2025
  • 227 Pages
  • Global
From
Loading Indicator

The Neoantigen market is a subset of the Genomics market that focuses on the identification and development of neoantigens for use in cancer immunotherapy. Neoantigens are proteins that are produced by tumor cells and are recognized by the immune system as foreign, triggering an immune response. By targeting these neoantigens, cancer immunotherapy can be used to treat cancer. Companies in the Neoantigen market are focused on developing technologies to identify and develop neoantigens for use in cancer immunotherapy. Companies in the Neoantigen market include Adaptive Biotechnologies, I-Mab, Neoantigen Therapeutics, NeoVax, and OncoImmune. Show Less Read more